Integra LifeSciences (NSDQ:IART) shares got a boost this morning on third-quarter results that topped the consensus forecast. IART shares were up 5.6% at $70.95 per share in early morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.2%. The Princeton, New Jersey-based surgical and […]
Integra LifeSciences
Integra Lifesciences announces new CEO
Integra LifeSciences (NSDQ:IART) announced today that former Barco CEO Jan D. De Witte will take over the corner office at Integra by the end of the year. De Witte left Barco effective September 1. He will succeed Peter J. Arduini, who is leaving Integra Lifesciences to lead GE Healthcare. The top spot at Integra will […]
Integra Lifesciences raises guidance on Street-beating Q2 results
Integra LifeSciences (NSDQ:IART) today posted second-quarter results that beat the overall consensus on Wall Street. The Princeton, N.J.–based surgical and medical instrument company reported profits of $35.1 million, to 41¢ per share, on sales of $389.9 million, for the three months ended June 30, for a sales growth of 50.8% compared with Q2 2020. Earnings per […]
MedTech 100 roundup: Nearing new highs once again
Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set […]
Integra Lifesciences CEO steps down to succeed GE Healthcare CEO Murphy
Integra LifeSciences (NSDQ:IART) announced today that Peter Arduini will step down as CEO to accept a new role leading GE Healthcare (NYSE:GE). Princeton, N.J.–based Integra said in a news release that Arduini will step down at the end of 2021 to become president & CEO at GE Healthcare. Current president and CEO of GE Healthcare, […]
Integra Lifesciences ticks up before hours on Street-beating Q1 results
Integra LifeSciences (NSDQ:IART) today posted first-quarter results that beat the consensus on Wall Street. The company reported profits of $45.4 million, or 53¢ per share, on sales of $360.1 million for the three months ended March 31, for a bottom-line gain of 394.5% on sales growth of 1.62% compared with Q1 2020. Adjusted to exclude one-time […]
The top 7 medtech CEO quotes on COVID-19, one year later
The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world […]
Integra LifeSciences posts earnings beat in Q4
Integra LifeSciences (NSDQ:IART) shares dipped today despite fourth-quarter results that beat the consensus earnings forecast. The Princeton, N.J.-based medtech company posted profits of $92.7 million, or $1.09 per share, on sales of $388.6 million for the three months ended Dec. 31, 2020, coming in well ahead of its Q4 2019 profit of $15.3 million despite a […]
Smith + Nephew closes Extremity Orthopedics purchase
Integra LifeSciences (NSDQ:IART) announced today that it completed the divestiture of its extremity orthopedics business to Smith+Nephew (NYSE:SNN). The companies previously announced the planned divestiture, worth $240 million, in September 2020. At the time, London-based Smith+Nephew said that the acquisition would significantly strengthen its extremities business by adding a combination of a focused sales channel and complimentary […]
Integra LifeSciences to acquire ACell
Integra LifeSciences (NSDQ:IART) today said it entered into a definitive agreement to acquire ACell. Through the deal, Integra LifeSciences will pay $300 million in cash upfront at closing, subject to customary purchase price adjustments with cash payments of up to an additional $100 million upon certain revenue growth milestones. Columbia, Md.-based ACell currently develops The MatriStem […]
Smith+Nephew to buy Integra extremities business for $240M
Smith+Nephew (NYSE:SNN) announced today that it agreed to acquire the extremity orthopedics business from Integra LifeSciences (NSDQ:IART) for $240 million. London-based Smith+Nephew said in a news release that the acquisition will significantly strengthen its extremities business by adding a combination of a focused sales channel and complimentary shoulder replacement and upper and lower extremities portfolios, plus a […]